Table 1.
n-3 PUFA | Nearest gene | SNP | Chr. position | EA/NEA | EAF | Effect | SE | p-value | VE (%) | F |
---|---|---|---|---|---|---|---|---|---|---|
ALA | FEN1 | rs412334 | 11:61316837 | t/c | 0.16 | − 0.0118 | 0.0016 | 9.72E−14 | 0.342 | 30 |
C11orf9 | rs198464 | 11:61278197 | a/g | 0.50 | − 0.0057 | 0.0009 | 2.48 E−11 | 0.148 | 13 | |
C11orf10 | rs740006 | 11:61314444 | t/c | 0.90 | 0.0163 | 0.0025 | 1.32 E−10 | 0.440 | 39 | |
C11orf9 | rs17762402 | 11:61309777 | a/g | 0.07 | − 0.0186 | 0.0029 | 1.56 E−10 | 0.411 | 37 | |
DHA | ELOVL2 | rs2236212 | 6:10995015 | c/g | 0.41 | − 0.1132 | 0.0141 | 1.26 E−15 | 0.646 | 58 |
DPA | ELOVL2 | rs3734398 | 6:10982973 | t/c | 0.57 | − 0.0404 | 0.0029 | 9.61 E−44 | 2.667 | 243 |
FEN1 | rs412334 | 11:61560261 | t/c | 0.16 | 0.0554 | 0.0052 | 1.40 E−26 | 2.750 | 251 | |
C11orf10 | rs740006 | 11:61557868 | t/c | 0.9 | − 0.0764 | 0.0079 | 4.50 E−22 | 3.502 | 322 | |
FADS3 | rs7394871 | 11:61652514 | a/c | 0.05 | − 0.0637 | 0.0078 | 3.56 E−16 | 1.285 | 115 | |
FADS2 | rs498793 | 11:61624705 | t/c | 0.43 | 0.0307 | 0.0038 | 5.84 E−16 | 1.540 | 139 | |
SYCP2L | rs12199131 | 6:10932569 | a/g | 0.26 | 0.0267 | 0.0033 | 7.69 E−16 | 0.914 | 82 | |
RAB3IL1 | rs174472 | 11:61671956 | a/g | 0.58 | 0.0274 | 0.0037 | 5.74 E−14 | 1.219 | 109 | |
C11orf9 | rs17762402 | 11:61553201 | a/g | 0.06 | 0.0805 | 0.0109 | 1.42 E−13 | 2.437 | 221 | |
SYCP2L | rs6928281 | 6:10908917 | t/g | 0.72 | 0.0226 | 0.0032 | 8.04 E−13 | 0.686 | 61 | |
C11orf9 | rs198464 | 11:61521621 | a/g | 0.49 | 0.0191 | 0.0028 | 7.47 E−12 | 0.608 | 54 | |
FADS2 | rs17156442 | 11:61614023 | t/c | 0.05 | − 0.0513 | 0.0077 | 2.09 E−11 | 0.833 | 74 | |
BEST1 | rs1109748 | 11:61722645 | a/c | 0.07 | − 0.0400 | 0.0068 | 5.09 E−09 | 0.694 | 62 | |
ELOVL2 | rs6936315 | 6:11035972 | t/c | 0.84 | 0.0244 | 0.0043 | 1.34 E−08 | 0.533 | 48 | |
FTH1 | rs10792320 | 11:61746291 | a/c | 0.65 | 0.0160 | 0.0030 | 8.49 E−08 | 0.388 | 35 | |
BEST1 | rs2727266 | 11:61704334 | a/g | 0.93 | 0.0308 | 0.0058 | 8.86 E−08 | 0.412 | 37 | |
EPA | FADS3 | rs7394871 | 11:61652514 | a/c | 0.05 | − 0.0912 | 0.0128 | 1.13 E−12 | 0.494 | 44 |
ELOVL2 | rs3798713 | 6:11008622 | c/g | 0.42 | 0.0350 | 0.0050 | 1.93 E−12 | 0.373 | 33 | |
BEST1 | rs1109748 | 11:61722645 | a/c | 0.07 | − 0.0535 | 0.0092 | 5.46 E−09 | 0.233 | 21 | |
FEN1 | rs412334 | 11:61560261 | t/c | 0.16 | 0.0440 | 0.0081 | 4.59 E−08 | 0.325 | 29 | |
FADS2 | rs498793 | 11:61624705 | t/c | 0.43 | 0.0351 | 0.0064 | 5.11 E−08 | 0.377 | 34 | |
MAT2B | rs1145652 | 5:164764087 | a/g | 0.87 | 0.0356 | 0.0066 | 8.39 E−08 | 0.179 | 16 |
ALA α-linolenic acid, Chr. chromosome, DHA docosahexaenoic acid, DPA docosapentaenoic acid, EA effect allele, EAF effect allele frequency, EPA eicosapentaenoic acid, F F-statistic, NEA non-effect allele, PUFAs polyunsaturated fatty acids, SE standard error, SNP single nucleotide polymorphism, VE variation explained
VE (%) = (2 × Effect2 × EAF × (1 − EAF)/var (n-3 PUFAs)) × 100, var (n-3 PUFA) is the variance of n-3 PUFA and was deduced based on literature data (PMID: 27490808). F-statistic is a measure of the strength of the genetic instrument and is calculated as follows: F = (R2 × (n − 1 − k))/((1 − R2) × k), where R2 = VE (%), n = sample size, k = number of instrumental variables